Showing results (41-50 of 284) with videos related to
Sort By:
Pageof 29
Journal of Neural Transmission (Vienna, Austria : 1996)|January 23, 2024
Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists viewJeswinder Sian-Hulsmann, Peter RiedererJournal of Neural Transmission (Vienna, Austria : 1996)|April 23, 2020
The role of alpha-synuclein as ferrireductase in neurodegeneration associated with Parkinson's diseaseJeswinder Sian-Hulsmann, Peter RiedererCells|April 3, 2021
The Nigral Coup in Parkinson's Disease by α-Synuclein and Its Associated RebelsJeswinder Sian-Hulsmann, Peter RiedererJournal of Neural Transmission (Vienna, Austria : 1996)|July 30, 2020
Coronaviruses: a challenge of today and a call for extended human postmortem brain analysesPeter Riederer, Volker Ter MeulenAdvances in Therapy|February 20, 2017
Pooled Analysis of Four Non-Interventional Studies: Effectiveness and Tolerability of the Antidepressant Agomelatine in Daily PracticeGerd Laux, Bettina Barthel, Göran Hajak, et al.International Journal of Psychiatry in Clinical Practice|June 18, 2014
Driving ability in schizophrenic patients: effects of neurolepticsMichael Soyka, Sabine Kagerer, Alexander Brunnauer, et al.The Journal of Clinical Psychiatry|January 2, 2007
Antidepressants and driving ability: results from a clinical studyAlexander Brunnauer, Gerd Laux, Elisabeth Geiger, et al.Clinical Neuropharmacology|July 7, 2017
Determination of Monoamine Oxidase A and B Activity in Long-Term Treated Patients With Parkinson DiseaseThomas Müller, Peter Riederer, Edna GrünblattJournal of Neural Transmission (Vienna, Austria : 1996)|January 22, 2015
Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expressionMakoto Naoi, Peter Riederer, Wakako MaruyamaCurrent Pharmaceutical Design|February 3, 2004
Functional neurochemistry of Alzheimer's diseaseWieland Gsell, Gerd Jungkunz, Peter RiedererPageof 29